Pentamaster’s growing medical segment to continue revenue rise


CGS-CIMB Research revised its FY23 to FY25 earnings forecast for Pentamaster by 4.4% to 9.6%.

PETALING JAYA: Analysts expect Pentamaster Corp Bhd to experience a slowdown in its automotive segment due to competition from electric vehicles (EVs) that is likely to have an impact on the group moving forward.

CGS-CIMB Research said Pentamaster’s growing medical segment is expected to help cushion any near-term moderation in the group’s automotive segment.

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Ringgit to trade in narrow range against US dollar in holiday-shortened week ahead
Navigating Sarawak’s condominium market
Policies head in right direction
China underground: Affordable and sustainable homes
Trump travel ban adds to Caribbean woes
Asia rides the dollar dip
Bull charges cautiously
Beauty lovers turn to TikTok and Amazon
EM optimism after stellar year
Philippine stocks set for recovery

Others Also Read